Number of Shares
1.04 Mil
Current Holdings Value*
$40.21 Mil
% of Portfolio
7.85%
Total Estimate Gain
$49.40 Mil
% of Total Estimate Gain
103.70%

Grosvenor Holdings, L.L.C.'s Fate Therapeutics Inc Holding Summary

As of 2022-03-31, Grosvenor Holdings, L.L.C. held 1.04 Mil shares of Fate Therapeutics Inc(FATE), totaling $40.21 Mil. This investment constitutes 7.85% of their stock portfolio, and Grosvenor Holdings, L.L.C. now holds 1.07% of the outstanding Fate Therapeutics Inc(FATE) stock.

The initial trade took place in 2019Q3. And since then Grosvenor Holdings, L.L.C. has made 2 purchases of FATE, at an average price of $19.73, for a total of 2.41 Mil shares. In addition, there have been 5 sales at an average price of $69.62 for 1.38 Mil shares. Based on historical transaction data and FATE's current price of $1.13, Grosvenor Holdings, L.L.C.'s estimated gain on his FATE holdings is $49.40 Mil, reflecting a 103.70% gain to date.

Grosvenor Holdings, L.L.C. FATE ($1.13) Holding Chart

Grosvenor Holdings, L.L.C. FATE ($1.13) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1